Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.
作者： Danhua Zhu , Ming Tu , Bo Zeng , Lin Cai , Weiming Zheng
DOI: 10.1002/CAM4.987
关键词:
摘要: … glioma cells to TMZ . Our results demonstrated that overexpression of miR‐497 is significantly correlated with TMZ resistance in glioma … for treatment of chemotherapy‐resistant glioma. …
sci-hub.se 参考文章(32)
Stuart H. Burri, Roshan S. Prabhu, Ashley L. Sumrall, Wendy Brick, Brian D. Blaker, Brent E. Heideman, Peggy Boltes, Renee Kelly, James T. Symanowski, Walter F. Wiggins, Lynn Ashby, H. James Norton, Kevin Judy, Anthony L. Asher, BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial. Journal of Neuro-oncology. ,vol. 123, pp. 259- 266 ,(2015) , 10.1007/S11060-015-1793-2
Lei Chang, Peter H. Graham, Jie Ni, Jingli Hao, Joseph Bucci, Paul J. Cozzi, Yong Li, Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance. Critical Reviews in Oncology Hematology. ,vol. 96, pp. 507- 517 ,(2015) , 10.1016/J.CRITREVONC.2015.07.005
Xuan Wang, Meichen Wang, Hongmin Li, Xi Lan, Li Liu, Jiaxi Li, Yue Li, Jing Li, Jing Yi, Xiaojuan Du, Jidong Yan, Yan Han, Fujun Zhang, Min Liu, Shemin Lu, Dongmin Li, Upregulation of miR-497 induces hepatic insulin resistance in E3 rats with HFD-MetS by targeting insulin receptor. Molecular and Cellular Endocrinology. ,vol. 416, pp. 57- 69 ,(2015) , 10.1016/J.MCE.2015.08.021
Kaiyao Hua, Chuankui Wei, Dengfeng Li, Jialu Song, Qifeng Luo, Hongming Song, Xiaoguo Sun, Lin Fang, Xiaoyu Li, MicroRNA-497 induces cell apoptosis by negatively regulating Bcl-2 protein expression at the posttranscriptional level in human breast cancer. International Journal of Clinical and Experimental Pathology. ,vol. 8, pp. 7729- 7739 ,(2015)
Xue-jun Shao, Mei-hua Miao, Jun Xue, Jian Xue, Xue-qiang Ji, Hong Zhu, The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma Cellular Physiology and Biochemistry. ,vol. 36, pp. 2051- 2062 ,(2015) , 10.1159/000430172
XIONG CHEN, YINGYING ZHANG, YINGYING SHI, HAIWEI LIAN, HUILIN TU, SONG HAN, BIWEN PENG, WANHONG LIU, XIAOHUA HE, miR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2 International Journal of Oncology. ,vol. 47, pp. 1603- 1611 ,(2015) , 10.3892/IJO.2015.3143
Lei Shi, Guan Sun, Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro Neuromolecular Medicine. ,vol. 17, pp. 431- 442 ,(2015) , 10.1007/S12017-015-8372-8
Shaohua Xu, Guang-Bo Fu, Zhen Tao, Jun OuYang, Fanfei Kong, Bing-Hua Jiang, Xiaoping Wan, Ke Chen, MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1 Oncotarget. ,vol. 6, pp. 26457- 26471 ,(2015) , 10.18632/ONCOTARGET.4762
Lei Shi, Xifeng Fei, Zhimin Wang, Yongping You, PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway. In Vitro Cellular & Developmental Biology – Animal. ,vol. 51, pp. 1047- 1055 ,(2015) , 10.1007/S11626-015-9931-X
Gina Leisching, Benjamin Loos, Matthys Botha, Anna-Mart Engelbrecht, Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance. Journal of Translational Medicine. ,vol. 13, pp. 328- 328 ,(2015) , 10.1186/S12967-015-0689-4